Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2005

View Archived Issues

Phase II trial examines ADH-1 in N-cadherin expressing tumors

Recruitment begins in phase IIb study of DB-289 for malaria

Tsumura to file U.S. IND for Dai-kenchu-to

VEGF Trap studied in combination with FOLFOX4 regimen

TopoTarget signs CRADA for PXD-101

PulmoLAR designated orphan drug for PAH

FDA approval for phase IIb kidney transplant study of ISA-247

Cephalon to acquire Salmedix

FAS-20013 demonstrates killing effect against TB

NiKem Research and Hybrigenics expand USP inhibitor agreement

Compassionate use IND cleared for Davanat/5-FU

CCX-282 alleviates the severity of ileitis and colitis in experimental IBD

PCL-016 shows promise for adenovirus ocular infections

N-Acetylfarnesylcysteine: a novel class of topical NSAID

AJM-300 suppresses lymphocyte homing and ameliorates colitis in rats

Access and Hunter-Fleming form oral drug delivery collaboration

Genmab's new HuMax-CD38 program for multiple myeloma

Eye drops with FGLM-NH2 plus IGF-1 reported effective in neurotrophic keratopathy

Serenex selects Hsp90 inhibitors for advanced preclinical studies

Canadian approval sought for pivotal study of BST-CarGel

New immunomodulatory agents disclosed by Mitsubishi Pharma

Novel antiarthritic agents covered in recent patent literature

Syk kinase inhibitors for allergic disorders emerge from Rigel research

New agents for the treatment of lipoprotein disorders reported by Pfizer

GW-8510 and other substituted 3' substituted indolones offer neuroprotective potential

PARP-1 inhibition is neuroprotective in model of traumatic brain injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....